Compare · ACH vs ILMN
ACH vs ILMN
Side-by-side comparison of Accendra Health Inc. (ACH) and Illumina Inc. (ILMN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ACH and ILMN operate in Medical Specialities (Health Care), so they compete in similar markets.
- ILMN is the larger of the two at $24.59B, about 113.5x ACH ($216.7M).
- Over the past year, ACH is down 59.4% and ILMN is up 97.3% - ILMN leads by 156.7 points.
- ILMN has been more active in the news (24 items in the past 4 weeks vs 20 for ACH).
- ILMN has more recent analyst coverage (25 ratings vs 2 for ACH).
- Company
- Accendra Health Inc.
- Illumina Inc.
- Price
- $2.71-4.07%
- $161.39-0.69%
- Market cap
- $216.7M
- $24.59B
- 1M return
- -26.95%
- +15.79%
- 1Y return
- -59.43%
- +97.30%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NYSE
- NASDAQ
- IPO
- 2000
- News (4w)
- 20
- 24
- Recent ratings
- 2
- 25
Accendra Health Inc.
Aluminum Corporation of China Limited, together with its subsidiaries, manufactures and sells alumina, primary aluminum, and energy products in the People's Republic of China. The company operates through Alumina, Primary Aluminum, Trading, and Energy segments. The Alumina segment mines for and purchases bauxite and other raw materials; and produces and sells alumina, as well as refined alumina. The Primary Aluminum segment procures alumina and other raw materials, supplemental materials, and electrical power; and produces and sells aluminum and aluminum-related products, such as carbon, aluminum alloy, and other electrolytic aluminum products. The Trading segment trades in alumina, primary aluminum, aluminum fabrication products, other non-ferrous metal products, coal products, raw and supplemental materials; and provides logistics and transport services to external customers. The Energy segment engages in coal mining; and generates and sells electricity using thermal power, wind power, and solar power sources to regional power grid corporations, as well as manufactures power related equipment. The company also acquires, manufactures, and distributes bauxite mines and limestone ore; and provides engineering project management, and research and development services. Aluminum Corporation of China Limited was incorporated in 2001 and is headquartered in Beijing, the People's Republic of China.
Illumina Inc.
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. It has a collaboration agreement with Geneseeq Technology Inc. to develop comprehensive in-vitro diagnostic (IVD) NGS testing kits for cancer. The company was incorporated in 1998 and is headquartered in San Diego, California.
Latest ACH
- SEC Form SD filed by Accendra Health Inc.
- Accendra Health Inc. filed SEC Form 8-K: Regulation FD Disclosure
- Accendra Health Announces Offers and Consent Solicitations
- EVP,General Counsel & CorpSecy Galloway Heath H covered exercise/tax liability with 1,822 shares, decreasing direct ownership by 1% to 166,306 units (SEC Form 4) to satisfy withholding obligation
- EVP & CFO Leon Jonathan A covered exercise/tax liability with 1,770 shares, decreasing direct ownership by 0.61% to 290,533 units (SEC Form 4) to cover withholding tax
- President & CEO Pesicka Edward A covered exercise/tax liability with 17,692 shares, decreasing direct ownership by 2% to 1,072,785 units (SEC Form 4) to satisfy withholding obligation
- EVP,General Counsel & CorpSecy Galloway Heath H covered exercise/tax liability with 966 shares, decreasing direct ownership by 0.57% to 168,128 units (SEC Form 4) (tax liability)
- EVP, Chief Operating Officer Bernocchi Perry A covered exercise/tax liability with 7,908 shares, decreasing direct ownership by 2% to 313,913 units (SEC Form 4) to satisfy withholding tax
- Director Kline Teresa L. was granted 31,191 shares, increasing direct ownership by 58% to 85,316 units (SEC Form 4)
- Director Klemash Stephen W was granted 31,191 shares, increasing direct ownership by 53% to 90,242 units (SEC Form 4)
Latest ILMN
- Director Meister Keith A. sold $107,042,631 worth of shares (669,596 units at $159.86) (SEC Form 4)
- Chief Legal Officer Davies Scott M sold $98,400 worth of shares (615 units at $160.00), decreasing direct ownership by 3% to 21,568 units (SEC Form 4)
- VP, Chief Accounting Officer Ericksen Scott D sold $305,150 worth of shares (2,000 units at $152.57), decreasing direct ownership by 12% to 14,446 units (SEC Form 4)
- Integrated DNA Technologies Announces End-to-End Oncology Research Workflows Optimized on Illumina Software for Faster Insights
- Amendment: SEC Form 4 filed by Director Meister Keith A.
- Illumina and SPT Labtech unveil fireflyGO, enabling faster, simpler targeted oncology research
- Illumina introduces the first distributed whole-genome sequencing solution for highly sensitive MRD research
- Illumina Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- Director King David P was granted 2,072 shares (SEC Form 4)
- Director Siegel Susan E was granted 2,072 shares, increasing direct ownership by 14% to 16,535 units (SEC Form 4)